Skip to main content

Peer Review reports

From: Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study

Original Submission
28 Jun 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
14 Sep 2023 Author responded Author comments - Shengyuan Yu
Resubmission - Version 4
14 Sep 2023 Submitted Manuscript version 4
8 Oct 2023 Reviewed Reviewer Report
19 Oct 2023 Reviewed Reviewer Report
31 Oct 2023 Author responded Author comments - Shengyuan Yu
Resubmission - Version 5
31 Oct 2023 Submitted Manuscript version 5
13 Nov 2023 Author responded Author comments - Shengyuan Yu
Resubmission - Version 6
13 Nov 2023 Submitted Manuscript version 6
14 Nov 2023 Reviewed Reviewer Report
14 Nov 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
27 Nov 2023 Editorially accepted
15 Dec 2023 Article published 10.1186/s12883-023-03477-z

You can find further information about peer review here.

Back to article page